Variant report

Variant	esv3384021
Chromosome Location	chr11:63802326-63804424
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:65)
CpG islands
(count:427)
Chromatin interactive
region (count:6)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:65 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:63802876-63802981	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr11:63804009-63804180	K562	blood:	n/a	n/a
3	CEBPB	chr11:63802448-63802686	HepG2	liver:	n/a	chr11:63802588-63802599
4	CHD2	chr11:63803946-63804212	K562	blood:	n/a	n/a
5	CHD2	chr11:63804042-63804223	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr11:63804069-63804269	HepG2	liver:	n/a	n/a
7	CTCF	chr11:63803940-63804090	HMEC	breast:	n/a	chr11:63804033-63804046
8	CTCF	chr11:63803800-63803950	HFF	foreskin:	n/a	n/a
9	CTCF	chr11:63803840-63803990	SAEC	small airway:	n/a	n/a
10	CTCF	chr11:63803919-63804179	IMR90	lung:	n/a	chr11:63804033-63804046
11	CTCF	chr11:63803800-63803950	SK-N-SH_RA	brain:	n/a	n/a
12	CTCF	chr11:63803920-63804070	AG04449	skin:	n/a	chr11:63804033-63804046
13	CTCF	chr11:63804000-63804150	AG04449	skin:	n/a	chr11:63804033-63804046
14	CTCF	chr11:63803760-63803910	WERI-Rb-1	eye:	n/a	n/a
15	CTCF	chr11:63803957-63804139	K562	blood:	n/a	chr11:63804033-63804046
16	CTCF	chr11:63803800-63803950	NHDF-neo	bronchial:	n/a	n/a
17	CTCF	chr11:63803820-63803970	SK-N-SH_RA	brain:	n/a	n/a
18	CTCF	chr11:63803840-63803990	HCM	heart:	n/a	n/a
19	CTCF	chr11:63803980-63804130	RPTEC	kidney:	n/a	chr11:63804033-63804046
20	CTCF	chr11:63803820-63803970	NB4	blood:	n/a	n/a
21	CTCF	chr11:63803740-63803890	HRPEpiC	eye:	n/a	n/a
22	CTCF	chr11:63803900-63804050	HBMEC	blood vessel:	n/a	chr11:63804033-63804046
23	CTCF	chr11:63803920-63804070	HRPEpiC	eye:	n/a	chr11:63804033-63804046
24	CTCF	chr11:63803720-63803870	HEK293	kidney:	n/a	n/a
25	CTCF	chr11:63803000-63803150	SK-N-SH_RA	brain:	n/a	n/a
26	CTCF	chr11:63803860-63804010	HepG2	liver:	n/a	n/a
27	CTCF	chr11:63803973-63804099	ProgFib	skin:	n/a	chr11:63804033-63804046
28	CTCF	chr11:63804060-63804210	NB4	blood:	n/a	n/a
29	CTCF	chr11:63803720-63803870	WI-38	lung:	n/a	n/a
30	CTCFL	chr11:63803984-63804113	K562	blood:	n/a	n/a
31	E2F6	chr11:63803929-63804210	K562	blood:	n/a	n/a
32	EGR1	chr11:63803034-63803363	K562	blood:	n/a	chr11:63803077-63803090 chr11:63803081-63803091
33	EGR1	chr11:63803020-63803258	K562	blood:	n/a	chr11:63803077-63803090 chr11:63803081-63803091
34	FOS	chr11:63803940-63804250	HUVEC	blood vessel:	n/a	chr11:63804098-63804109
35	FOSL1	chr11:63803956-63804196	K562	blood:	n/a	chr11:63804100-63804111 chr11:63804098-63804109
36	MAX	chr11:63803961-63804129	K562	blood:	n/a	chr11:63803964-63803974
37	MAX	chr11:63803957-63804243	NB4	blood:	n/a	chr11:63803964-63803974
38	MAX	chr11:63803899-63804273	K562	blood:	n/a	chr11:63804263-63804273 chr11:63803964-63803974
39	MAX	chr11:63803894-63804319	SK-N-SH	brain:	n/a	chr11:63804263-63804273 chr11:63803964-63803974
40	MAZ	chr11:63802679-63805093	IMR90	lung:	n/a	chr11:63803069-63803079 chr11:63804263-63804273 chr11:63803964-63803974
41	MXI1	chr11:63803167-63804704	SK-N-SH	brain:	n/a	chr11:63804000-63804009
42	MYC	chr11:63803978-63804245	NB4	blood:	n/a	n/a
43	POLR2A	chr11:63803385-63803523	ProgFib	skin:	n/a	n/a
44	POLR2A	chr11:63803880-63803900	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr11:63802923-63803446	H1-neurons	neurons:	n/a	n/a
46	POLR2A	chr11:63802737-63803442	H1-neurons	neurons:	n/a	n/a
47	POLR2A	chr11:63803893-63805253	HL-60	blood:	n/a	n/a
48	POLR2A	chr11:63804269-63804530	H1-neurons	neurons:	n/a	n/a
49	POLR2A	chr11:63802777-63802879	K562	blood:	n/a	n/a
50	POLR2A	chr11:63802614-63802635	K562	blood:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:63803781-63803831	AG04449	skin:	fetal
2	chr11:63803781-63803831	HCF	heart:	n/a
3	chr11:63804119-63804169	MCF10A-Er-Src	breast:	n/a
4	chr11:63804021-63804071	T-47D	breast:	n/a
5	chr11:63804044-63804094	H1-hESC	embryonic stem cell:	embryo
6	chr11:63804044-63804094	NH-A	brain:	n/a
7	chr11:63803839-63803889	SK-N-SH	brain:	n/a
8	chr11:63804044-63804094	HepG2	liver:	n/a
9	chr11:63802973-63803023	NHDF-neo	bronchial:	n/a
10	chr11:63802973-63803023	NH-A	brain:	n/a
11	chr11:63803845-63803895	HEK293	kidney:	embryo
12	chr11:63804021-63804071	ovcar-3	ovarian:	n/a
13	chr11:63803781-63803831	HUVEC	blood vessel:	n/a
14	chr11:63804044-63804094	AoSMC	blood vessel:	n/a
15	chr11:63803845-63803895	CMK	blood:	n/a
16	chr11:63802973-63803023	T-47D	breast:	n/a
17	chr11:63803845-63803895	SK-N-MC	brain:	n/a
18	chr11:63803839-63803889	HIPEpiC	eye:	n/a
19	chr11:63804044-63804094	Hepatocyte	liver:	n/a
20	chr11:63804044-63804094	CMK	blood:	n/a
21	chr11:63803781-63803831	Jurkat	blood:	n/a
22	chr11:63803781-63803831	ProgFib	skin:	n/a
23	chr11:63802973-63803023	Hela-S3	cervix:	n/a
24	chr11:63804044-63804094	ProgFib	skin:	n/a
25	chr11:63803845-63803895	AG09309	skin:	n/a
26	chr11:63804044-63804094	RPTEC	kidney:	n/a
27	chr11:63803839-63803889	HL-60	blood:	n/a
28	chr11:63803845-63803895	PANC-1	pancreas:	n/a
29	chr11:63804119-63804169	NT2-D1	testis:	n/a
30	chr11:63802973-63803023	ovcar-3	ovarian:	n/a
31	chr11:63804021-63804071	HCT-116	colon:	n/a
32	chr11:63803845-63803895	NT2-D1	testis:	n/a
33	chr11:63803781-63803831	SKMC	muscle:	n/a
34	chr11:63802973-63803023	HL-60	blood:	n/a
35	chr11:63803845-63803895	Caco-2	colon:	n/a
36	chr11:63803839-63803889	GM12878	blood:	n/a
37	chr11:63804021-63804071	PrEC	prostate:	n/a
38	chr11:63803845-63803895	Hela-S3	cervix:	n/a
39	chr11:63802973-63803023	HEEpiC	esophagus:	n/a
40	chr11:63802973-63803023	HCM	heart:	n/a
41	chr11:63803781-63803831	HepG2	liver:	n/a
42	chr11:63804119-63804169	A549	lung:	n/a
43	chr11:63804021-63804071	HCF	heart:	n/a
44	chr11:63804044-63804094	HEEpiC	esophagus:	n/a
45	chr11:63802973-63803023	BJ	skin:	n/a
46	chr11:63804021-63804071	GM12891	blood:	n/a
47	chr11:63804021-63804071	Caco-2	colon:	n/a
48	chr11:63803781-63803831	RPTEC	kidney:	n/a
49	chr11:63804044-63804094	HCPEpiC	choroid plexus:	n/a
50	chr11:63802973-63803023	NB4	blood:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:63804025..63806335-chr11:63810879..63812713,2	K562	blood:
2	chr11:63804357..63806180-chr11:63931418..63933035,2	K562	blood:
3	chr11:63803810..63805326-chr11:63952443..63954679,2	MCF-7	breast:
4	chr11:63767256..63769371-chr11:63800817..63803162,2	MCF-7	breast:
5	chr11:63799424..63801976-chr11:63803879..63805403,2	K562	blood:
6	chr11:63794408..63798675-chr11:63803501..63805972,4	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FLRT1-2	chr11:63804224-63804247	NONHSAT021933

No data

Variant related genes	Relation type
ENSG00000256824	TF binding region
ENSG00000256824	CpG island
ENSG00000167770	chromatin interactions
ENSG00000168439	chromatin interactions

Extended variants
information (count: 61 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:61 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs556609109	chr11:63802378-63802379	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs576591529	chr11:63802435-63802436	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs35303643	chr11:63802438-63802439	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs545560969	chr11:63802516-63802517	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs181532790	chr11:63802576-63802577	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs487747	chr11:63802586-63802587	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs487811	chr11:63802617-63802618	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs560502892	chr11:63802683-63802684	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs529638890	chr11:63802731-63802732	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs76539208	chr11:63802748-63802749	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs112627983	chr11:63802787-63802788	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs532236828	chr11:63802796-63802797	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs376302466	chr11:63802808-63802809	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs552323995	chr11:63802812-63802813	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs71454588	chr11:63802823-63802824	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs577384525	chr11:63802855-63802856	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs539942957	chr11:63802888-63802889	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs73498113	chr11:63802895-63802896	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs184669300	chr11:63802900-63802901	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs11231680	chr11:63802913-63802914	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs536631646	chr11:63802923-63802924	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs556557293	chr11:63802989-63802990	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs556407568	chr11:63803177-63803178	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs570106017	chr11:63803178-63803179	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs370728970	chr11:63803186-63803187	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs538873516	chr11:63803206-63803207	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs558684038	chr11:63803214-63803215	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs545232734	chr11:63803246-63803247	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs572410248	chr11:63803261-63803262	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs541373716	chr11:63803282-63803283	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs112468302	chr11:63803339-63803340	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs554833885	chr11:63803416-63803417	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs544858159	chr11:63803484-63803485	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs189709017	chr11:63803492-63803493	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs563062749	chr11:63803529-63803530	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs181350591	chr11:63803566-63803567	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs61884700	chr11:63803627-63803628	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs559631690	chr11:63803629-63803630	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs112140372	chr11:63803647-63803648	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs320141	chr11:63803702-63803703	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs530643120	chr11:63803706-63803707	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs572320413	chr11:63803776-63803777	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs540839789	chr11:63803781-63803782	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs568337732	chr11:63803888-63803889	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs530061759	chr11:63803895-63803896	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs185895897	chr11:63803953-63803954	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs528893346	chr11:63803958-63803959	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs373670213	chr11:63803985-63803986	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs35254056	chr11:63804054-63804055	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs550115255	chr11:63804151-63804152	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21785460	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Anaplastic thyroid cancer	18753363	CNVD
Prostate cancer	18779856	CNVD
Cancer	17160897	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:385 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:63786600-63858000	Weak transcription	Hela-S3	cervix
2	chr11:63796600-63802600	Weak transcription	Ovary	ovary
3	chr11:63796600-63802600	Weak transcription	Right Ventricle	heart
4	chr11:63796800-63802400	Weak transcription	Pancreas	Pancrea
5	chr11:63797800-63802600	Weak transcription	Brain Angular Gyrus	brain
6	chr11:63798000-63802400	Weak transcription	Brain Inferior Temporal Lobe	brain
7	chr11:63798400-63802400	Enhancers	Skeletal Muscle Male	skeletal muscle
8	chr11:63798600-63802400	Enhancers	Skeletal Muscle Female	skeletal muscle
9	chr11:63800000-63802600	Weak transcription	Psoas Muscle	Psoas
10	chr11:63801400-63802600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr11:63801400-63802800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
12	chr11:63801600-63802600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr11:63801600-63802800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
14	chr11:63801600-63802800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
15	chr11:63801600-63802800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr11:63801600-63803000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr11:63801800-63802400	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
18	chr11:63801800-63802600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
19	chr11:63801800-63803000	Bivalent Enhancer	Fetal Heart	heart
20	chr11:63802000-63802400	Bivalent Enhancer	Fetal Brain Male	brain
21	chr11:63802000-63802400	Enhancers	A549	lung
22	chr11:63802000-63802600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr11:63802000-63802600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr11:63802000-63802600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
25	chr11:63802000-63802600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
26	chr11:63802000-63802600	Enhancers	Brain Germinal Matrix	brain
27	chr11:63802000-63802600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
28	chr11:63802000-63802800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
29	chr11:63802000-63802800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
30	chr11:63802000-63802800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
31	chr11:63802000-63802800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
32	chr11:63802000-63802800	Bivalent Enhancer	Fetal Muscle Leg	muscle
33	chr11:63802000-63803000	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
34	chr11:63802200-63802400	Bivalent Enhancer	Fetal Brain Female	brain
35	chr11:63802200-63802400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
36	chr11:63802200-63802600	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr11:63802200-63802600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr11:63802200-63802600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
39	chr11:63802200-63802600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr11:63802200-63802600	Bivalent Enhancer	Colonic Mucosa	Colon
41	chr11:63802200-63802600	Bivalent Enhancer	Fetal Stomach	stomach
42	chr11:63802200-63802800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr11:63802200-63802800	Enhancers	Brain Substantia Nigra	brain
44	chr11:63802200-63802800	Bivalent Enhancer	Esophagus	oesophagus
45	chr11:63802200-63803000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
46	chr11:63802200-63803000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
47	chr11:63802200-63803200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr11:63802400-63802600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
49	chr11:63802400-63802600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr11:63802400-63802600	Bivalent Enhancer	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links